propranolol has been researched along with Dyskinesia, Medication-Induced in 38 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Excerpt | Relevance | Reference |
---|---|---|
"In Parkinson's disease (PD), the long term use of L-DOPA results in major adverse effects including dyskinesia or abnormal involuntary movements." | 1.36 | The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. ( Buck, K; Ferger, B, 2010) |
"Progress in the treatment of action myoclonus is especially noteworthy and has led to the implication of serotonin deficit in the pathophysiology of this syndrome." | 1.26 | New approaches in the management of hyperkinetic movement disorders. ( Fahn, S, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (73.68) | 18.7374 |
1990's | 7 (18.42) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (7.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhide, N | 2 |
Lindenbach, D | 2 |
Barnum, CJ | 2 |
George, JA | 1 |
Surrena, MA | 2 |
Bishop, C | 2 |
Buck, K | 1 |
Ferger, B | 1 |
Goldenberg, AA | 1 |
Tignor, S | 1 |
Klioueva, A | 1 |
Walters, H | 1 |
Bacher, NM | 1 |
Lewis, HA | 2 |
Kulik, FA | 2 |
Wilbur, R | 3 |
Chaudhry, R | 1 |
Radonjic, D | 1 |
Waters, B | 1 |
Schrodt, GR | 1 |
Wright, JH | 1 |
Simpson, R | 1 |
Moore, DP | 1 |
Chase, S | 1 |
Kurlan, R | 1 |
Shoulson, I | 1 |
Perényi, A | 1 |
Farkas, A | 1 |
Bacher, NA | 1 |
Karniol, IG | 1 |
Portela, W | 1 |
Lipinski, JF | 1 |
Zubenko, GS | 1 |
Barreira, P | 1 |
Cohen, BM | 1 |
Kulik, AV | 1 |
Kuehnle, JC | 1 |
Johnson, JM | 1 |
Ratey, JJ | 1 |
Salzman, C | 1 |
Olivera, AA | 1 |
Kiefer, MW | 1 |
Pitts, FN | 1 |
Einarson, TR | 1 |
Risch, SC | 1 |
Cohen, RM | 1 |
Kalin, NH | 1 |
Roberts, PW | 1 |
Sachdev, P | 2 |
Loneragan, C | 1 |
Metzer, WS | 1 |
Paige, SR | 1 |
Newton, JE | 1 |
Kalian, M | 1 |
Lerner, V | 1 |
Goldman, M | 1 |
Ahlskog, JE | 1 |
Shamrakov, O | 1 |
Berner, Y | 1 |
Costall, B | 1 |
Naylor, RJ | 1 |
Nohria, V | 1 |
Owen, RT | 1 |
Snyder, SH | 1 |
Fahn, S | 1 |
Adler, LA | 1 |
Angrist, B | 1 |
Rotrosen, J | 1 |
Chee, KY | 1 |
Frost, L | 1 |
Lal, S | 1 |
Yassa, R | 1 |
Cooper, SJ | 1 |
Doherty, MM | 1 |
King, DJ | 1 |
Petit, H | 1 |
Catteau, J | 1 |
Dumon, JP | 1 |
Libert, C | 1 |
Gelenberg, AJ | 1 |
Novac, A | 1 |
Sandyk, R | 1 |
5 reviews available for propranolol and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Up and down regulation: clinical significance of nervous system receptor-drug interactions.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Humans; Nervo | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Medical treatment of later-stage motor problems of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; | 1999 |
Receptors, neurotransmitters and drug responses.
Topics: Animals; Antipsychotic Agents; Behavior; Brain Chemistry; Cyclic AMP; Dyskinesia, Drug-Induced; Enke | 1979 |
Treating extrapyramidal reactions: some current issues.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans | 1987 |
7 trials available for propranolol and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Femal | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Intravenous benztropine and propranolol challenges in tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Benztropine; Cross-Over Studies; Double-Blind Method; Dyski | 1993 |
Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Dyskine | 1993 |
Metoprolol versus propranolol.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Metoprolol; Middle Aged; Neurologic E | 1990 |
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztr | 1990 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
27 other studies available for propranolol and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.
Topics: Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Co | 2015 |
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 2010 |
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Neurons; Animals; Behavior, An | 2012 |
Low-dose propranolol in tardive dyskinesia.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Male; Midd | 1980 |
Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease, Second | 1980 |
Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Humans; | 1980 |
Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Drug Therapy, Combination; Dys | 1982 |
Treatment of tardive dyskinesia with propranolol.
Topics: Adult; Aged; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Ma | 1982 |
Propranolol in the treatment of tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Prop | 1983 |
Propranolol, anxiety, and tardive dyskinesia.
Topics: Antipsychotic Agents; Anxiety; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Proprano | 1983 |
Propranolol in the treatment of neuroleptic-induced akathisia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Propranolol; Restless Legs Syndrome | 1983 |
Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Ind | 1983 |
Neuroleptic-induced akathisia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Propranolol | 1983 |
Recognizing and managing akathisia.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Ben | 1984 |
Propranolol therapy in a patient with panic disorder, tardive dyskinesia, and essential tremor.
Topics: Adult; Anxiety Disorders; Dyskinesia, Drug-Induced; Fear; Humans; Male; Panic; Propranolol; Tremor | 1984 |
Treatment of tardive dyskinesia with propranolol.
Topics: Dyskinesia, Drug-Induced; Humans; Propranolol | 1982 |
Use of propranolol in treating tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Humans; Propranolol | 1981 |
Propranolol, chlorpromazine, and tardive dyskinesia.
Topics: Biological Availability; Chlorpromazine; Drug Interactions; Dyskinesia, Drug-Induced; Propranolol | 1980 |
The use of propranolol in treating tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Propranolol | 1980 |
Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; | 1993 |
Response of elderly women with thyrotoxicosis to treatment for tardive dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 1999 |
Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers.
Topics: Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Mice; Motor Acti | 1978 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclo | 1977 |
Neuroleptic-induced marching-in-place.
Topics: Adult; Antipsychotic Agents; Benztropine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Humans; | 1989 |
[Treatment of akathisia of neuroleptics by propranolol].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Propranolol | 1985 |
Improvement in tardive dyskinesia and MMPI scores with propranolol.
Topics: Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; MMPI; Propranolol; Psychotic Disorders | 1986 |
Propranolol-induced tardive dyskinesia in a patient with akathisia.
Topics: Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Middle Aged; Parkinson Disease, Secondary; Pr | 1985 |